NEWS
Institutional Subscription: Comprehensive Analyses to Enhance Your Global and Local Impact
New Feature: Compare Your Institution with the Previous Year
Find a Professional: Explore Experts Across 197 Disciplines in 221 Countries!
Find a Professional
Print Your Certificate
New! Young University / Institution Rankings 2025
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
Highly Cited Researchers 2025
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
Login
Register & Pricing
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Reports
person
Find a Professional
James Larkin
Royal Marsden Hospital - London / United Kingdom
Others
AD Scientific Index ID: 4919887
Registration, Add Profile,
Premium Membership
Print Your Certificate
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Subject Leaders
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
James Larkin's MOST POPULAR ARTICLES
1-)
Improved survival with vemurafenib in melanoma with BRAF V600E mutationPB Chapman, A Hauschild, C Robert, JB Haanen, P Ascierto, J Larkin, ...New England Journal of Medicine 364 (26), 2507-2516, 201185082011
2-)
Intratumor heterogeneity and branched evolution revealed by multiregion sequencingM Gerlinger, AJ Rowan, S Horswell, J Larkin, D Endesfelder, E Gronroos, ...N Engl j Med 366, 883-892, 201278842012
3-)
Combined nivolumab and ipilimumab or monotherapy in untreated melanomaJ Larkin, V Chiarion-Sileni, R Gonzalez, JJ Grob, CL Cowey, CD Lao, ...New England journal of medicine 373 (1), 23-34, 201569232015
4-)
Pembrolizumab versus ipilimumab in advanced melanomaC Robert, J Schachter, GV Long, A Arance, JJ Grob, L Mortier, A Daud, ...New England Journal of Medicine 372 (26), 2521-2532, 201564132015
5-)
Nivolumab versus everolimus in advanced renal-cell carcinomaRJ Motzer, B Escudier, DF McDermott, S George, HJ Hammers, S Srinivas, ...New England Journal of Medicine 373 (19), 1803-1813, 201562522015
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept